We are delighted to announce the launch of Promatix Inc, an ALSA Group company that is using multi-omics to develop the next generation of cancer therapeutics. Read more about it on the website here: pro-matix.com #proteomics #multiomics #oncology #innovation #biotech

Rene Hoet joins the Montis Biosciences team as CSO, bringing extensive experience in #antibody drug discovery and development Read more about it here: alsaventures.com/news/montis-bi… #oncology #innovation #biotech

Congratulations to Prof. Peter Carmeliet, one of the academic #founders of portfolio company Montis Biosciences , for being elected as an International Honorary Member of the prestigious American Academy of Arts & Sciences (#AAAS) vib.be/news/internati…

Read our latest blog post on how #COVID-19 has impacted allocation of venture capital in biotech here: alsaventures.com/post/has-covid… #biotech #investing #venturecapital

Congratulations to portfolio company Montis Biosciences for being awarded a #VLAIO #grant, which will be used to support the innovative work they are doing in immune-oncology. Read more about it here: alsaventures.com/news/montis-bi… #biotech #oncology #innovation #funding